These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8129394)

  • 1. [Dose effects on vital parameters of guinea pig by continuous administration of cisplatin].
    Chiba Y; Kano Y
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):525-30. PubMed ID: 8129394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration.
    Leite EA; Giuberti Cdos S; Wainstein AJ; Wainstein AP; Coelho LG; Lana AM; Savassi-Rocha PR; De Oliveira MC
    Life Sci; 2009 May; 84(19-20):641-9. PubMed ID: 19302806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
    Yamada T
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
    Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
    González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
    Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.
    Ekborn A; Lindberg A; Laurell G; Wallin I; Eksborg S; Ehrsson H
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):36-42. PubMed ID: 12497204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase.
    Zhang J; Wang X; Lu H
    Cancer Lett; 2008 Feb; 260(1-2):127-36. PubMed ID: 18039557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice.
    Li XM; Metzger G; Filipski E; Boughattas N; Lemaigre G; Hecquet B; Filipski J; Levi F
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):281-90. PubMed ID: 9144445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity studies of Cupric Sulfate (CAS No. 7758-99-8) Administered in Drinking Water and Feed to F344/N Rats and B6C3F1 Mice.
    Hebert C
    Toxic Rep Ser; 1993 Jul; 29():1-D3. PubMed ID: 12209195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cisplatin-induced toxicity by selected dithiocarbamates.
    Walker EM; Fazekas-May MA; Heard KW; Yee S; Montague D; Jones MM
    Ann Clin Lab Sci; 1994; 24(2):121-33. PubMed ID: 8203821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
    Nakata B; Hirakawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats.
    Saad SY; Najjar TA; Alashari M
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):862-7. PubMed ID: 15659050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic intravenous toxicity studies with gamma-cyclodextrin in rats.
    Donaubauer HH; Fuchs H; Langer KH; Bär A
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):189-98. PubMed ID: 9671574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.